Previous 10 | Next 10 |
NORTHAMPTON, MA / ACCESSWIRE / January 4, 2024 / Quest Diagnostics recently provided no-cost Blueprint for Wellness® testing to more than 100 local community members who attended a wellness day in the Mississippi Delta region. The ninth annual I-HEAL Community Wellness Day, hosted by Quest ...
Quest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire SECAUCUS, N.J. , Dec. 21, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic information services, announced that...
Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer PR Newswire Seasoned healthcare executive and oncologist joins Executive Leadership Team SECAUCUS, N.J. , Dec. 20, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: D...
Quest Diagnostics Launches New 88-Compound Novel Psychoactive Substance Test Panel PR Newswire Xylazine found in 1 in 12 specimens tested, finds new 'Drug Misuse in America' Health Trends® report on the rising polysubstance crisis SECAUCUS, N.J. , Dec. 19, 2...
Haystack Oncology and Rutgers Cancer Institute Collaborate to use Haystack MRD™ in Clinical Study of Early-Stage Triple-Negative Breast Cancer PR Newswire BALTIMORE , Dec. 14, 2023 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company,...
NORTHAMPTON, MA / ACCESSWIRE / December 13, 2023 / Quest Diagnostics Originally published in Quest Diagnostics Corporate Responsibility Report 2022 2025/2026 Goals Implement a waste-to-energy strategy to divert from landfills' waste from several of our laboratory locations by 2025 Reduc...
2023-12-12 12:08:05 ET BofA has raised its rating on Quest Diagnostics ( NYSE: DGX ) to buy, calling it "growth at a reasonable price." The investment bank said it had downgraded the stock in May over concerns about the company’s near-term expansion and its acquisition of...
Quest Diagnostics Incorporated (NYSE: DGX) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 1.35% on the day to $129.41. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United ...
NORTHAMPTON, MA / ACCESSWIRE / December 11, 2023 / Quest Diagnostics More than 1,100 Community Health Centers - also called Federally Qualified Health Centers, or FQHC - today provide affordable, comprehensive care to over 30 million children and adults across the United States. Since 1965, Com...
2023-12-08 07:22:17 ET Summary Quest Diagnostics is a global leader in diagnostic testing, information, and services, providing diverse products to a broad clientele. The company capitalized on COVID-19 testing to boost earnings. However, post-pandemic, the decline in revenues det...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-24 07:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $154.00 for DGX on 2024-07-24 06:36:00. The adjusted price target was set to $154.00. At the time of the announcement, DGX was trading at $140.96. The overall price target consensus is at ...